US2007067861A1PendingUtilityA1
Cloning pigs using donor nuclei from differentiated cells
Est. expiryJan 10, 2017(expired)· nominal 20-yr term from priority
A61P 35/00A61P 3/10A61P 9/04A61P 9/00A61P 31/18A61P 25/00A61P 25/28A61P 25/16A61P 17/00A61K 35/12A01K 67/027A61P 13/02A61P 21/00A61P 19/00A61P 1/18C12N 5/0603A01K 2217/05C12N 15/8771A61P 1/16C12N 2510/00A01K 2227/101C12N 2517/02C12N 15/8778A61P 17/02A01K 67/0273C12N 2517/04A01K 67/0275A61K 38/00
60
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
An improved method of nuclear transfer involving the transplantation of donor differentiated pig cell nuclei into enucleated pig oocytes is provided. The resultant nuclear transfer units are useful for multiplication of genotypes and transgenic genotypes by the production of fetuses and offspring. Production of genetically engineered or transgenic pig embryos, fetuses and offspring is facilitated by the present method since the differentiated cell source of the donor nuclei can be genetically modified and clonally propagated.
Claims
exact text as granted — not AI-modified1 . A method of cloning a pig fetus, comprising:
(i) inserting a desired differentiated pig cells or cell nuclei into enucleated, metaphase-II pig oocytes, under conditions suitable for the formation of nuclear transfer (NT) units; (ii) activating the resultant nuclear transfer units; and (iii) synchronously transferring 20 or more of said activated NT units into a host pig such that one or more of the NT units develops into a fetus.
2 . (canceled)
3 . The method according to claim 1 , wherein a desired DNA is inserted, removed or modified in said differentiated pig cell or nucleus, thereby resulting in the production of a genetically altered NT unit.
4 . (canceled)
5 . The method according to claim 1 , which comprises culturing said activated nuclear transfer unit until greater than the 2-cell developmental stage.
6 . The method according to claim 1 , wherein the differentiated pig cell or nucleus is derived from mesoderm.
7 . The method according to claim 1 , wherein the differentiated pig cell or nucleus is derived from ectoderm.
8 . The method according to claim 1 , wherein the differentiated pig cell or nucleus is derived from endoderm.
9 . The method according to claim 1 , wherein the differentiated pig cell or nucleus is a fibroblast cell or cell nucleus.
10 . The method according to claim 1 , wherein the differentiated pig cell or nucleus is an adult cell or cell nucleus.
11 . The method according to claim 1 , wherein the differentiated pig cell or nucleus is an embryonic or fetal cell or cell nucleus.
12 . The method according to claim 1 , wherein the enucleated oocyte is matured prior to enucleation.
13 . The method according to claim 1 , wherein the fused nuclear transfer unit is activated by exposure to two electrical pulses.
14 . The method according to claim 1 , wherein the fused nuclear transfer unit is activated by exposure to a single electrical pulse.
15 . The method according to claim 1 , wherein the fused nuclear transfer unit is activated by exposure to at least one activating factor derived from sperm cells.
16 . The method according to claim 3 , wherein microinjection is used to insert a heterologous DNA.
17 . The method according to claim 3 , wherein electroporation is used to insert a heterologous DNA.
18 - 78 . (canceled)
79 . A method of cloning a pig, comprising:
(i) inserting desired differentiated pig cells or cell nuclei into enucleated, metaphase-II pig oocytes, under conditions suitable for the formation of nuclear transfer (NT) units; (ii) activating the resultant nuclear transfer units; and (iii) synchronously transferring 20 or more of said activated NT units into a host pig such that one or more of the NT units develops into a pig.
80 . The method according to claim 79 , wherein a desired DNA is inserted, removed or modified in said differentiated pig cell or nucleus, thereby resulting in the production of a genetically altered NT unit.
81 . The method according to claim 79 , which comprises culturing said activated nuclear transfer unit until greater than the 2-cell developmental stage.
82 . The method according to claim 79 , wherein the differentiated pig cell or nucleus is derived from mesoderm.
83 . The method according to claim 79 , wherein the differentiated pig cell or nucleus is derived from ectoderm.
84 . The method according to claim 79 , wherein the differentiated pig cell or nucleus is derived from endoderm.
85 . The method according to claim 79 , wherein the differentiated pig cell or nucleus is a fibroblast cell or cell nucleus.
86 . The method according to claim 79 , wherein the differentiated pig cell or nucleus is an adult cell or cell nucleus.
87 . The method according to claim 79 , wherein the differentiated pig cell or nucleus is an embryonic or fetal cell or cell nucleus.
88 . The method according to claim 79 , wherein the enucleated oocyte is matured prior to enucleation.
89 . The method according to claim 79 , wherein the fused nuclear transfer unit is activated by exposure to two electrical pulses.
90 . The method according to claim 79 , wherein the fused nuclear transfer unit is activated by exposure to a single electrical pulse.
91 . The method according to claim 79 , wherein the fused nuclear transfer unit is activated by exposure to at least one activating factor derived from sperm cells.
92 . The method according to claim 80 , wherein microinjection is used to insert a heterologous DNA.
93 . The method according to claim 80 , wherein electroporation is used to insert a heterologous DNA.Join the waitlist — get patent alerts
Track US2007067861A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.